Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma
Background and Aim: Placental Growth Factor (PlGF) plays a crucial role in angiogenesis and was identified as a potential prognostic biomarker in various types of cancer. Therefore, we evaluated the diagnostic accuracy and prognostic value of PlGF serum concentration in patients with clear cell rena...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2021-11-01
|
| Series: | Biomedical Papers |
| Subjects: | |
| Online Access: | https://biomed.papers.upol.cz/artkey/bio-202104-0004_diagnostic-and-prognostic-value-of-placental-growth-factor-serum-concentration-in-clear-cell-renal-cell-carcino.php |
| _version_ | 1819195320806932480 |
|---|---|
| author | Marcela Cechova Matus Chocholaty Marek Babjuk Tomas Zima Klara Havlova Marketa Koldova Marek Schmidt Marta Kalousova |
| author_facet | Marcela Cechova Matus Chocholaty Marek Babjuk Tomas Zima Klara Havlova Marketa Koldova Marek Schmidt Marta Kalousova |
| author_sort | Marcela Cechova |
| collection | DOAJ |
| description | Background and Aim: Placental Growth Factor (PlGF) plays a crucial role in angiogenesis and was identified as a potential prognostic biomarker in various types of cancer. Therefore, we evaluated the diagnostic accuracy and prognostic value of PlGF serum concentration in patients with clear cell renal cell carcinoma (ccRCC). Patients and Methods: A total of 49 patients subjected to partial or radical nephrectomy for ccRCC [localized without relapse (lccRCC; n=31), localized with later relapse (rccRCC; n=8), primary metastatic cancer (mccRCC; n=10); median of follow-up 4.4 years] were enrolled in a prospective study to assess the significance of PlGF serum concentration. PlGF was measured prior to surgery and 3 months postoperatively. Our control group consisted of 38 healthy subjects. Results: PlGF serum concentration was significantly higher in ccRCC compared to controls (P=0.002). The cut-off value of PlGF concentration for the risk of ccRCC was determined at 12.71 pg/mL (AUC=0.729; P=0.0001). Prior to surgery, among ccRCC subgroups, significantly higher PlGF concentration was detected in mccRCC compared to lccRCC (P=0.002). Postoperatively, we observed a tendency to higher PlGF serum concentration in rccRCC compared to lccRCC subgroup, however without significance (P=0.17). The cut-off value for the risk of relapse was 11.41 pg/mL (AUC=0.792; P=0.0003). In subjects with localized ccRCC with PlGF concentration below 11.41 pg/mL 3-years cancer specific survival was 93% compared to 61% in subject with concentration above the cut-off value (P=0.018). Conclusion: Based on our findings, PlGF serum concentration seems to be a useful biomarker in diagnostics and prediction of prognosis in ccRCC. |
| first_indexed | 2024-12-23T02:10:53Z |
| format | Article |
| id | doaj.art-2f0e69117d8a4b63859c4fc8180da4e3 |
| institution | Directory Open Access Journal |
| issn | 1213-8118 1804-7521 |
| language | English |
| last_indexed | 2024-12-23T02:10:53Z |
| publishDate | 2021-11-01 |
| publisher | Palacký University Olomouc, Faculty of Medicine and Dentistry |
| record_format | Article |
| series | Biomedical Papers |
| spelling | doaj.art-2f0e69117d8a4b63859c4fc8180da4e32022-12-21T18:03:46ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212021-11-011654375379bio-202104-0004Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinomaMarcela Cechova0Matus Chocholaty1Marek Babjuk2Tomas Zima3Klara Havlova4Marketa Koldova5Marek Schmidt6Marta Kalousova7Department of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicInstitute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech RepublicInstitute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech RepublicBackground and Aim: Placental Growth Factor (PlGF) plays a crucial role in angiogenesis and was identified as a potential prognostic biomarker in various types of cancer. Therefore, we evaluated the diagnostic accuracy and prognostic value of PlGF serum concentration in patients with clear cell renal cell carcinoma (ccRCC). Patients and Methods: A total of 49 patients subjected to partial or radical nephrectomy for ccRCC [localized without relapse (lccRCC; n=31), localized with later relapse (rccRCC; n=8), primary metastatic cancer (mccRCC; n=10); median of follow-up 4.4 years] were enrolled in a prospective study to assess the significance of PlGF serum concentration. PlGF was measured prior to surgery and 3 months postoperatively. Our control group consisted of 38 healthy subjects. Results: PlGF serum concentration was significantly higher in ccRCC compared to controls (P=0.002). The cut-off value of PlGF concentration for the risk of ccRCC was determined at 12.71 pg/mL (AUC=0.729; P=0.0001). Prior to surgery, among ccRCC subgroups, significantly higher PlGF concentration was detected in mccRCC compared to lccRCC (P=0.002). Postoperatively, we observed a tendency to higher PlGF serum concentration in rccRCC compared to lccRCC subgroup, however without significance (P=0.17). The cut-off value for the risk of relapse was 11.41 pg/mL (AUC=0.792; P=0.0003). In subjects with localized ccRCC with PlGF concentration below 11.41 pg/mL 3-years cancer specific survival was 93% compared to 61% in subject with concentration above the cut-off value (P=0.018). Conclusion: Based on our findings, PlGF serum concentration seems to be a useful biomarker in diagnostics and prediction of prognosis in ccRCC.https://biomed.papers.upol.cz/artkey/bio-202104-0004_diagnostic-and-prognostic-value-of-placental-growth-factor-serum-concentration-in-clear-cell-renal-cell-carcino.phpplacental growth factorplgfclear cell renal cell carcinomabiomarkerdiagnosisprognosis |
| spellingShingle | Marcela Cechova Matus Chocholaty Marek Babjuk Tomas Zima Klara Havlova Marketa Koldova Marek Schmidt Marta Kalousova Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma Biomedical Papers placental growth factor plgf clear cell renal cell carcinoma biomarker diagnosis prognosis |
| title | Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| title_full | Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| title_fullStr | Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| title_full_unstemmed | Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| title_short | Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| title_sort | diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma |
| topic | placental growth factor plgf clear cell renal cell carcinoma biomarker diagnosis prognosis |
| url | https://biomed.papers.upol.cz/artkey/bio-202104-0004_diagnostic-and-prognostic-value-of-placental-growth-factor-serum-concentration-in-clear-cell-renal-cell-carcino.php |
| work_keys_str_mv | AT marcelacechova diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT matuschocholaty diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT marekbabjuk diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT tomaszima diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT klarahavlova diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT marketakoldova diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT marekschmidt diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma AT martakalousova diagnosticandprognosticvalueofplacentalgrowthfactorserumconcentrationinclearcellrenalcellcarcinoma |